is for 120,000 bottles. Identifying details on this dosage of the recalled drug are: Atomoxetine Capsules, USP, 10 milligram (mg) Manufactured for: Glenmark Pharmaceuticals Inc., NJ, USA ...

Recommended dosing of atomoxetine is weight based, and dosages should be adjusted to a target dosage of 1.2 mg/kg/day in children and adolescents weighing 70 kg or less and to 80 mg/day in ...

Glenmark Pharmaceuticals, an India-based drug manufacturer has issued a voluntary recall affecting nearly 1.48 million bottles of atomoxetine, a generic medication used to treat ADHD.

The recall affects around 14.76 lakh bottles of Atomoxetine Capsules in various strengths, produced by Glenmark ...

Glenmark Pharmaceuticals is recalling close to 15 lakh bottles of a generic medication used in the treatment of attention deficit hyperactivity disorder in the US market, according to the US health ...

Subjects received a single dose of placebo, atomoxetine (20, 45, and 90 mg), and methylphenidate (20 ... in patients with narrow-angle glaucoma. [10] Growth of children taking atomoxetine should ...